Best Stocks to Buy: Stock Recommendations for Week of June 1, 2026 – Checklist

Stock market recommendations: Astra microwaveand Shaili Engineering Plastics Recommended by Wealth Management Research Bureau Motilal Oswal as a Top stocks to buy For the week beginning June 1, 2026:

Astra microwaveASTRA delivered a strong performance for FY26, with results beating estimates due to better margins and 29% higher year-on-year inflows to INR 16.6 billion. Export momentum strengthened in Q4 FY26, supported by higher value RF systems and SDR-related opportunities.

ASTRA’s key growth drivers include the Uttam radar, QRSAM, Su-30 upgrades, electronic warfare systems, weather radars and strategic space programs.The company is targeting FY27 revenue of INR 13-14 billion, implying 15-20% YoY growth through stronger execution and higher contributions from production orders. It aims to nearly triple revenues by fiscal year 2030-31, supported by strategic defense programs, improved operating leverage, and better cash flow generation.We upgraded FY27/FY28 estimates to reflect stronger flows and margins, with revenue/EBITDA/EBIT expected to grow at a CAGR of 20%/17%/30% over FY26-28.Shaili Engineering PlasticsShaily Engineering Plastics has built nearly four decades of microplastics manufacturing experience, serving global leaders in the healthcare, consumer, personal care, appliance, automotive and lighting industries. Its strong innovation capabilities and diverse customer base include IKEA, Unilever, Gillette, P&G, GE and Garrett.

SHEP’s healthcare business is seeing strong momentum as a result of rising demand for GLP-1 and insulin pens following the expiration of the semaglutide patent in key emerging markets. Backed by strong order visibility and single supplier tie-ups, the company plans to expand five-fold in pen manufacturing capacity to over 150 million units by FY28.We expect the strong growth momentum to continue, supported by volume commitments from key healthcare customers. We expect SHEP to register a CAGR of 29%/38%/43% in revenue/EBITDA/EBITDA over FY26-28, while maintaining EBITDA margin at 32%+. We expect ROE/ROE to expand to ~28%/36% in FY28E.

(Disclaimer: Recommendations, opinions regarding stock market, other asset classes or personal finance management tips provided by experts are their own. These opinions do not represent the views of The Times Of India.)